Allergy Immunotherapy Program from The Wellness Company
Frequently Asked Questions
How does allergen immunotherapy work?
The exact mechanism by which desensitization immunotherapy like AllergyFree switches off allergies is uncertain, but there are several working theories:
One theory has been that AllergyFree works by helping your body naturally produce a specific antibody which blocks IgE, which is an allergy-triggering substance in your body. During the course of treatment, the levels of IgE fall, and IgG rise – naturally tricking your body into becoming both less reactive to allergies, but also making your body produce more of a natural substance to block them.
Another theory is that immunotherapy like AllergyFree modulates T-helper cells, which causes switching (of what?) from predominantly TH2 (an [antibody?] which induces creation of IgE – the substance which makes your body react to allergies) to predominantly TH1 (which induces creation of IgG (the allergy-blocking antibody).
Either way, your allergy symptoms drop along with your levels of allergy-triggering IgE throughout and after treatment with AllergyFree.
Is this program safe for children?
Absolutely! Allergy Immunotherapy Program is safe for people ages 5 and up.
What if my symptoms persist after 12 months?
Most patients who finish their drops are symptom-free by the end of the 12 month program. You may continue the program if your provider deems you suitable.
How long does the treatment last?
This is a 12-month treatment which includes monthly shipments of drops that are placed underneath the tongue every day.
How does the treatment reduce medication dependence and eliminate unwanted side effects?
Adding daily antigens to your body will gradually increase your threshold for an immune response. Over time, these effects will accumulate and create a higher tolerance to environmental allergens that previously triggered an immune response.
Can pregnant women take TWC Allergy Immunotherapy Program allergy drops?
Taking AllergyFree is not recommended for pregnant women. However, if you are already taking sublingual immunotherapy drops and become pregnant, you can continue AllergyFree at a stable dose throughout your pregnancy.
The Research Behind AllergyFree
Our unique immunotherapy program is based on scientifically-tested, research-driven antigen formulations that steer your body’s immune response to allergens away from the symptoms you're accustomed to, and toward being 100% symptom-free.
The science behind AllergyFree
Selected peer-reviewed articles about sublingual immunotherapy treatment (SLIT)
1. Sublingual Immunotherapy for Allergic Rhinitis and Conjunctivitis
Giovanni Passalacqua, Valentina Garelli, Francesca Sclifò, Giorgio Walter Canonica Immunotherapy. 2013;5(3):257-264.
2. Adult and Pediatric Clinical Trials of Sublingual Immunotherapy in the USA
Dai Park, Nora Daher, Michael S Blaiss Expert Rev Clin Immunol. 2012;8(6):557-564.
3. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Lin SY1, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB.Erratum in JAMA. 2013 Aug 14;310(6):647
4. Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis.
Author information Shao J1, Cui YX, Zheng YF, Peng HF, Zheng ZL, Chen JY, Li Q, Cao LF.
5. Oral mucosal immunotherapy for allergic rhinitis: A pilot study
William R. Reisacher, M.D.,1 Maria V. Suurna, M.D.,1 Kate Rochlin, Ph.D.,2 Maria G. Bremberg, R.N.,1 and Guy Tropper, M.D.3 (Allergy Rhinol 7:e21–e28, 2016; doi: 10.2500/ar.2016.7.0150)
1. Sublingual Immunotherapy for Allergic Rhinitis and Conjunctivitis
Giovanni Passalacqua, Valentina Garelli, Francesca Sclifò, Giorgio Walter Canonica Immunotherapy. 2013;5(3):257-264.
2. Adult and Pediatric Clinical Trials of Sublingual Immunotherapy in the USA
Dai Park, Nora Daher, Michael S Blaiss Expert Rev Clin Immunol. 2012;8(6):557-564.
3. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Lin SY1, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB.Erratum in JAMA. 2013 Aug 14;310(6):647
4. Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis.
Author information Shao J1, Cui YX, Zheng YF, Peng HF, Zheng ZL, Chen JY, Li Q, Cao LF.
5. Oral mucosal immunotherapy for allergic rhinitis: A pilot study
William R. Reisacher, M.D.,1 Maria V. Suurna, M.D.,1 Kate Rochlin, Ph.D.,2 Maria G. Bremberg, R.N.,1 and Guy Tropper, M.D.3 (Allergy Rhinol 7:e21–e28, 2016; doi: 10.2500/ar.2016.7.0150)
Still have questions?
Our customer service team is some of the best – and are available to answer your questions.
We can even put you in touch with our medical team if you have questions before beginning your treatment.
help@twc.health
800-758-1584
These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Allergen Warning: This product is produced in an a facility that may also process ingredients containing milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans.
Intended for use by adults 18 years of age and over. Do not use if the seal under the cap is broken or missing. Please contact a healthcare practitioner or email askadoc@twc.health before taking or using this supplement. Keep out of the reach of children.